Lv5
910 积分 2024-02-29 加入
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
4小时前
已完结
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
5小时前
待确认
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
5小时前
已完结
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
5小时前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
1个月前
已完结
Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
2个月前
已完结
Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China
2个月前
已完结
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts
2个月前
已完结
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
2个月前
已完结
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
3个月前
已完结
皖公网安备34019202002308
